Sumary of People with preexisting mental disorders at increased risk for COVID-19-related mortality:
- July 22, 2021 3 min read Source/Disclosures Disclosures: De Picker reports receiving grants from Boehringer-Ingelheim and Janssen, outside the submitted work, as well as being a member of the ECNP Immunopsychiatry Thematic Working Group.
- Please see the study for all other authors’ relevant financial disclosures.
- “Together with my co-authors and five major European psychiatric associations, we have strongly advocated to include patients with severe mental illness as a priority group in the national COVID-19 vaccination strategies,” Livia J.
- De Picker, MD, a psychiatrist and postdoctoral researcher at the University Psychiatric Hospital Duffel in Belgium, told Healio Psychiatry.
- “While several countries did change their policy in response to our campaign, policymakers in other countries discarded our pleas, stating that there was not sufficient evidence on which groups of patients were at risk for which particular outcomes.
- Crude ORs for mortality following SARS-CoV-2 infection, estimated via modelled random-effects meta-analyses, served as the primary outcome.
- De Picker and colleagues also conducted subgroup analyses and meta-regressions to evaluate the effects of baseline COVID-19 treatment setting, patient age, country, pandemic phase, quality assessment score, sample sizes and adjustment for confounders.
- According to results of subgroup analyses and meta-regressions, significant associations existed between mortality and COVID-19 treatment setting (P = .